Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity. Heemskerk N, Gruijs M, Temming AR, Heineke MH, et al. J Clin Invest 2021;131.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Heemskerk N, Gruijs M, Temming AR, Heineke MH, et al. Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity. J Clin Invest 2021;131.
PMID: 33561014